Compare Fabrinet (FN) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fabrinet vs Revolution Medicines Inc. Common Stock — how do they compare? Fabrinet trades at $499.77 (market cap $17.46B), while Revolution Medicines Inc. Common Stock trades at $189.1 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 2.3× Fabrinet's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Fabrinet nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fabrinet for 30 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| FN | RVMD | |
|---|---|---|
Market Cap | $17.46B | $40.32B |
Volume | 1,199,886 | 4,855,734 |
Sector | Technology | Health |
52-Week High | $746.47 | $221.15 |
52-Week Low | $361.94 | $47.50 |
Typical Hold Time | 30 Days | 0 Days |
Enterprise Value | $16.59B | $37.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fabrinet (FN) trades at $497.99, up 1.81% today, with a bullish technical signal and strong analyst support. The stock shows robust fundamentals, including a 45% year-over-year revenue growth in Q4 2026 and consistent earnings beats, driven by surging AI data center demand. Valuation ratios like P/E of 37.34 and P/S of 3.81 reflect high growth expectations. Recent news highlights capacity expansion and AI-driven growth, though high RSI levels suggest potential overbought conditions.
The outlook for FN is positive, with a consensus price target of $769.50 implying significant upside. Key opportunities include AI infrastructure demand and operational leverage, but risks involve customer concentration, margin pressure from high spending, and insider selling. Investors should weigh strong growth prospects against valuation and execution risks in a competitive sector.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Fabrinet
Fabrinet provides advanced optical and electromechanical manufacturing services to original equipment manufacturers. It specializes in complex products for telecom, automotive, and medical industries.
Read more on FN →About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →
